Get started
Author

Madeline R. Pellegrino

Observed names: M Pellegrino, M R Pellegrino, M. Pellegrino, Madeline Pellegrino
Institution: Mayo Clinic
OpenAlex ID: A5112177794
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
2024 · Theodore J. Kottom, Kimberly E. Stelzig, et al. · Drugs in R&D · 5
Preclinical and Toxicology Assessment of ISFP10, an Inhibitor of Fungal Phosphoglucomutase (PGM)
2025 · Madeline R. Pellegrino, Marc Bindzus, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
The importance of Fcγ and C-type lectin receptors in host immune responses during Pneumocystis pneumonia
2024 · Theodore J. Kottom, Eva M. Carmona, et al. · Infection and Immunity · 3
The Tyrosine Kinase Receptor EphA2 in Alveolar Macrophages Provides a Protective Role in Host Defense Against Pneumocystis Pneumonia
2026 · Theodore J Kottom, Madeline Pellegrino, et al. · The Journal of Infectious Diseases · 1
Anti-Fungal and Toxicology Assessment of ISFP10, an Inhibitor of Fungal Phosphoglucomutase (PGM)
2026 · Madeline R. Pellegrino, Marc Bindzus, et al. · Drugs in R&D
PDF
C27-10 EphA2 Receptor Tyrosine Kinase Regulates Alveolar Macrophage Inflammatory Responses During Pneumocystis Pneumonia
2026 · A H Limper, T J Kottom, et al. · American Journal of Respiratory and Critical Care Medicine
C27-09 Targeting Phosphoglucomutase (PGM) as a Novel Antifungal Strategy in Pneumocystis: Functional and Therapeutic Evidence Supporting a Conserved Cysteine Target
2026 · A H Limper, T J Kottom, et al. · American Journal of Respiratory and Critical Care Medicine
Inhibition of Candida Auris Phosphoglucomutase – A Novel Therapeutic Target
2025 · J.W. Barwatt, T.J. Kottom, et al. · American Journal of Respiratory and Critical Care Medicine
[Multicenter study of the immunostimulating activity of a bacterial lysate].
1987 · M Pellegrino, B Palmieri, et al. · PubMed
Works count: 9
Citation count: 13
H-index: 3
I10-index:
Year
Topic
Type